Clinical Trial Update: Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating drug sensitivity testing-based tumor organoids to guide adjuvant therapy after liver tumor resection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Hepatocellular Carcinoma Resectable | Phase 2 | Status: NOT_YET_RECRUITING